retatrutide news today recency 3 First phase data, a Triumph of Science! What caught my attention wasn't

Early optimism in the use of GLP-1 therapies for Parkinsons disease has been tempered by the recent failure of a Phase III exenatide trial which did not show any benefits of slowing Parkinsons progression 10

The GLP-1 messages your pancreas to make insulin, which pulls glucose from your blood and your blood sugar is lowered to healthy levels

Beyond the gut, people who took GLP-1 medications were also more likely to be diagnosed with problems in their bones and joints, like arthritis and tendinitis, compared with people taking other medications to manage their blood sugar

M.FujikawaT.LeeS.LordC

The real struggle up to this date hasnt been the increased weight loss that results, but rather replicating this finding from animal studies in the human population

Microdosing programs pair our unique support offerings with lower, individualized medication doses with the goal of supporting overall metabolic and physiologic health